• 대한두경부종양학회:학술대회논문집
• /
• 1995.11a
• /
• pp.201-202
• /
• 1995

• Proceedings of the Korean Society of Life Science Conference
• /
• 2003.05a
• /
• pp.77-77
• /
• 2003

• Proceedings of the Zoological Society Korea Conference
• /
• 2000.10a
• /
• pp.237.1-237
• /
• 2000

No Abstract, See Full Text

• Proceedings of the Korean Society of Dyers and Finishers Conference
• /
• 2010.03a
• /
• pp.88-89
• /
• 2010

• 한국생물공학회:학술대회논문집
• /
• 2000.04a
• /
• pp.153-156
• /
• 2000

Xylan, the major hemicellulose component of many plants, occurs naturally in a partially acetylated form and lignin, the most resistant component in plant cell wall degradation, is also attached to ${\beta}-1,4-linked-D-xylose$ backbone through the ester linkage. Esterases are required to release the esterified substituent and acetyl esterases are important in the complete degradation of acetylated polysaccharides, like pectins and xylans. The gene(Axe) encoding acetyl xylan estarase(AXE) was isolated from genomic ${\lambda}$ library from Aspergillus ficuum. Nucleotide sequencing of the Axe gene indicated that the gene was separated with two intervening sequences and the amino acid sequence comparison revealed that it was closely related to that from A. awamori with the 92 % indentity. Heterologous expression of AXE was conducted by using YEp352 and Saccharomyces cerevisae 2805 as a vector and host expression system, respectively. The Axe gene was placed between GAL1 promoter and GAL7 terminator and then this recombinant vector was used to transform S. cerevisiae 2805 strain. Culture filtrate of the transformed yeast was assayed for the presence of AXE activity by spectrophotometry and, comparing with the host strain, four to five times of enzyme activity was detected in culture filtrate of transformed yeast.

• The Journal of Internal Korean Medicine
• /
• v.21 no.5
• /
• pp.873-876
• /
• 2000

So-gal(消渴) is a oriental medical pathologic state that is characterized by 3 major symptoms - thirst, polyphasia, polyuria - of which especially thirst features Sang-so(上消). Diabetes mellitus and So-gal(消渴) have many points in common. But there are considerable differencies between them, because they have obviously different diagnostic bases from each other. That is, oriental medicine places more weight on symptoms than clinopathologic laboratory reports. This case of stroke patient complained of severe thirst and additional dryness in the mouth, choking sensation in the chest, hidrosis, insomnia, dark colored urine, constipation. The patient had no clinical history of diabetes mellitus. Based on oriental medical standards, we diagnosed the case as Sang-so(上消). Several herbal medicines were dispensed for 48 days. And considerably effective result were obtained. Object : 1 case of stroke patient who complained severe thirst. Medication : . Seonghyangjeonggisan for 5 days (2000. 6. 9 - 6. 13.) . Paljeongsan for 21 days (2000. 6. 14. -7. 5) . Ikwonsan for 8 days (2000. 7. 6 - 7. 13) . Okcheonsan for 14 days (2000. 7. 14 - 7. 27) Result : 1. After administration of Paljeongsan, dark colored urine turned normal. 2. After administration of Ikwonsan, dryness in the mouth improved. 3. After administration of Okcheonsan, thirst significantly improved. Constipation, choking sensation, hidrosis, insomnia also improved.

• CELLMED
• /
• v.3 no.2
• /
• pp.15.1-15.5
• /
• 2013

Previous reports showed that Compound Astragalus and Salvia miltiorrhiza extract (CASE), which was mainly composed of astragalosides, astragalus polysaccharide and salvianolic acids, inhibited hepatic fibrosis by mediating transforming growth factor-${\beta}$ (TGF-${\beta}$)/Smad signaling. Our aim was to examine the effects of CASE on D-galactosamine (D-GalN) treated liver injury in mice and carbon tetrachloride ($CCl_4$)-induced liver fibrosis in rats. CASE was administered to mice with D-GalN-induced liver injury and to rats with $CCl_4$-induced liver fibrosis, respectively. Liver injury was routinely evaluated by relative liver weight, serum levels of ALT, AST, hyaluronic acid (HA), hepatic malondialdehyde (MDA) content, superoxide dismutase (SOD) activity, hydroxyproline (HYP) and histopathologic changes. Treatment of mice with CASE (60, 120, and 240 mg/kg, ig) significantly lowered ALT, relative liver weight, and MDA levels when compared with D-GalN treated mice. CASE (120, 240 mg/kg) significantly lowered ALT, AST, HA, HYP, and MDA levels against $CCl_4$ treated rats. Decreased SOD level was reversed with CASE treatment. Upon histopathological examination, CASE treatment had significantly inhibitory effect on the progression of hepatic fibrosis in rats. These results indicate that CASE might be effective in treatment and prevention of acute and chronic hepatic injury due to its antioxidant activity.

• Asian Pacific Journal of Cancer Prevention
• /
• v.15 no.3
• /
• pp.1181-1186
• /
• 2014

Sialyltransferase gene expression is altered in several cancers, including examples in the cervix. Transcriptional regulation of the responsible genes depends on different promoters. We aimed to determine the association of single-nucleotide polymorphisms in the B3 promoter of the ST3GAL4 gene and the P1 promoter of the ST6GAL1 gene with cervical premalignant lesions or cervical cancer. A blood sample and/or cervical scrapes were obtained from 104 women with normal cytology, 154 with premalignant lesions and 100 with cervical cancer. We also included 119 blood samples of random donors. The polymorphisms were identified by sequencing from PCR products. For the B3 promoter, a fragment of 506 bp (from nucleotide -408 to +98) was analyzed, and for the P1 promoter a 490 bp (-326 to +164) fragment. The polymorphism analysis showed that at SNP rs10893506, genotypes CC and CT of the ST3GAL4 B3 promoter were associated with the presence of premalignant lesions (OR=2.89; 95%CI 1.72-4.85) and cervical cancer (OR=2.23; 95%CI 1.27-3.91). We detected only one allele of each polymorphism in the ST6GAL1 P1 promoter. We did not detect any genetic variability in the P1 promoter region in our study population. Our results suggest that the rs10893506 polymorphism -22C/T may increase susceptibility to premalignant and malignant lesions of the cervix.

• Bulletin of the Korean Chemical Society
• /
• v.35 no.9
• /
• pp.2753-2757
• /
• 2014

INtegrase Interactor 1 protein (INI1/hSNF5) or BRG1-associated factor 47 (BAF47) is a SWI/SNF-related matrix associated actin dependent regulator of chromatin subfamily B member. DNA binding domain of INI1/hSNF5 is cloned into E.coli expression vectors, pET32a and purified as a monomer using size exclusion chromatography. NMR data show that $INI1^{DBD}$ has folded state with high population of ${\alpha}$-helices. By fluorescence-quenching experiments, binding affinities between $INI1^{DBD}$ and two double stranded DNA fragments were determined as $29.9{\pm}2.6{\mu}M$ (GAL4_1) and $258.7{\pm}5.8$ (GAL4_2) ${\mu}M$, respectively. Our data revealed that DNA binding domain of INI1/hSNF5 binds to transcriptional DNA sequences, and it could play an important role as a transcriptional regulator.

• Journal of Microbiology and Biotechnology
• /
• v.32 no.2
• /
• pp.212-219
• /
• 2022

Recently, the efficacy of probiotics in treatment of neurodegenerative disorders has been reported in animal and clinical studies. Here, we assessed the effects of Bacillus coagulans JA845 in counteracting the symptoms of D-galactose (D-gal)/AlCl₃-induced Alzheimer's disease (AD) in a mice model through behavioral test, histological assessment and biochemical analysis. Ten weeks of pre-treatment with B. coagulans JA845 prevented cognitive decline, attenuated hippocampal lesion and protected neuronal integrity, which demonstrated the neuroprotective features of B. coagulans JA845 in vivo. We also found that supplementation of B. coagulans JA845 alleviated amyloid-beta deposits and hyperphosphorylated tau in hippocampus of D-gal/AlCl₃-induced AD model mice. Furthermore, B. coagulans JA845 administration attenuated oxidative stress and decreased serum concentration of inflammatory cytokines by regulating the Nrf2/HO-1 and MyD88/TRAF6/NF-κB pathway. Our results demonstrated for the first time that B. coagulans has the potential to help prevent cognitive decline and might be a novel therapeutic approach for the treatment of neurodegenerative diseases.